Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-01-18
2011-01-18
Haddad, Maher M (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C530S387100, C530S389200
Reexamination Certificate
active
07871782
ABSTRACT:
The present invention provides specific binding members that bind synaptophysin and which comprise: an antibody VH domain selected from the group consisting of the C1-3 VH domain (SEQ ID NO. 2) and a VH domain comprising a VH CDR3 with the amino acid sequence of SEQ ID NO. 12 and optionally one or more VH CDR's with an amino acid sequence selected from SEQ ID NO. 10 and SEQ ID NO. 11; and/or an antibody VL domain selected front the group consisting of the C1-3 VL domain (SEQ ID NO. 4) and a VL domain comprising one or more VL CDR's with an amino acid sequence selected from SEQ ID NO. 13, SEQ ID NO. 14 and SEQ ID NO. 15. The invention further provides related materials such as nucleic acids, kits and compositions, and also methods of use of the binding member, for instance in targeting entities to hepatic stellate cells which are implicated it liver fibrosis.
REFERENCES:
patent: 5346813 (1994-09-01), Bodenmueller et al.
patent: 5496705 (1996-03-01), Sugano et al.
patent: 5859205 (1999-01-01), Adair et al.
patent: 99/20749 (1999-04-01), None
Klimka et al., Human anti-CD30 recombinant antibodies by guided phage antibody selection using cell panning. British Journal of Cancer (2000) 83:252-260.
Beiboer et al.,Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent. J. Mol., Biol. (2000) 296:833-849.
Eduardo Padlan, Anatomy of the antibody molecule. Mol Immunol. Feb. 1994;31(3):169-217.
Portolano et al.,Lack of promiscuity in autoantigen-specific H and L chain combinations as revealed by human H and L chain “roulette”. J Immunol. Feb. 1, 1993;150(3):880-7.
Paul, Fundamental Immunology, 3rd Edition, 1993, pp. 292-295.
Rudikoff et al Single amino acid substitution altering antigen-binding specificity. Proc Natl Acad Sci U S A. Mar. 1982;79(6): 1979-83.
MacCallum et al Antibody-antigen interactions: contact analysis and binding site topography. J Mol Biol. Oct. 11, 1996;262(5):732-45.
Casset et al. A peptide mimetic of an anti-CD4 monoclonal antibody by rational desig. Biochem Biophys Res Commun. Jul. 18, 2003;307(1 ): 198-205.
Douglass et al., Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury. The Journal of Hepatology, 2008, 49:88-98.
Vajdos FF, et al., “Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis,” J Mol Biol. Jul. 5, 2002;320(2):415-28.
International Search Report and Written Opinion for Application No. PCT/GB2005/001190 dated Feb. 27, 2006 (13 pages).
Beljaars, L. et al., “Albumin modified with mannose 6-phosphate: a potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells,” Hepatology (1999) 29:1486-1493.
Beljaars, L. et al., “Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor,” J. Biol. Chem. (2000) 275(17):12743-12751.
Cassiman, D. et al., “Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers,” J. Hepatology (2002) 36(2):200-209.
Elrick, L.J. et al., “Generation of monoclonal human single chain antibody fragment to hepatic stellate cells—a potential mechanism for targeting liver anti-fibrotic therapeutics,” J. Hepatology (2005) 42(6):888-896.
Porter Andy
Wright Matthew
Haddad Maher M
Michael & Best & Friedrich LLP
The University Court of the University of Aberdeen
LandOfFree
Specific binding members against synaptophysin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Specific binding members against synaptophysin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Specific binding members against synaptophysin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2645427